David Duncan

Dr. Duncan is the former CEO of FBSciences. Prior to joining FBS, Dr. Duncan was the CEO of Pasteuria Bioscience, where he led the company through its first successful EPA registration and commercial launch of a biological nematicide for use on turf grass; and, most recently completed an exclusive technology partnership with Syngenta. In his role as CEO for Chlorogen, Dr. Dave helped raise $10M in two series of financing for the young biopharmaceutical company that developed and manufactured proteins for human therapy. Dr. Dave also served in various roles, including product development (US & Canada); marketing; government and regulatory affairs; and as both a commercial development and business unit executive during his 22 years at Monsanto Company. He was credited for helping the company transition from a traditional agricultural chemical company into the world’s leading producer of agricultural biotechnology products. Dr. Dave received a B.S. degree in biology from Indiana State University and both an M.S. in agronomy/turf grass management and a Ph.D. in herbicide physiology from Michigan State University. Dr. Dave serves on the boards and committees of several organizations.